NCT02493049View on ClinicalTrials.gov

Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG

Domperidone

Addition of Domperidone to current Disease Modifying Therapy.

Trial Locations (1)

T2N 2T9

Calgary MS Clinic at Foothills Medical Centre, Calgary

Sponsors
All Listed Sponsors
collaborator

Alberta Innovates Health Solutions

OTHER

lead

University of Calgary

OTHER